Clindamycin HCl Capsule, 300 mg, QTY: 30 Capsules per bottle, Rx Only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701. NDC#: 70518-3772-02

FDA recall notice · announced May 14, 2025 · Remedyrepack

Class II FDA/FSIS Class II: use may cause temporary or medically reversible adverse health consequences.

The product

Clindamycin HCl Capsule, 300 mg, QTY: 30 Capsules per bottle, Rx Only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701. NDC#: 70518-3772-02

Reason for recall

CGMP Deviations - products manufactured in a shared facility with Ezetimibe tablets.

Notes

Distribution: Within U.S - PA, VA, FL.
Lot/code information: Lot#: B3698036-033125, B3688703-032625, Exp.: 07/31/2026.
Quantity: 23 bottles/30 count- 690 capsules
Status: Ongoing
Products in this recall event:
- Clindamycin HCl Capsule, 300 mg, QTY: 30 Capsules per bottle, Rx Only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701. NDC#: 70518-3772-02 (D-0411-2025)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.